Table 2 provides a detailed description of the clinical data. We evaluated the differences in clinicopathological variables after stratifying patients based on CFHR4 expression using the Kruskal–Wallis test, and the level of CFHR4 was strongly correlated with age, sex, race, TNM stage, histologic grade, pathological stage, tumor status, residual tumor, vascular invasion and AFP level (Figures 5A–L). This evidence concerns the gene CFHR4 and neoplasm.